FDA.reportPublic FDA data

Revuforj 160 MG Oral Tablet

RxCUI
2698341
RxNorm name
Revuforj 160 MG Oral Tablet
Display name
Revuforj 160 MG Oral Tablet
Full name
Revuforj 160 MG Oral Tablet
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:03

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
RevuforjREVUMENIBSyndax Pharmaceuticals, Inc.6eb3cdbc-0e74-477d-82d6-3bb172d3f63f2026-02-04Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2698341

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
6eb3cdbc-0e74-477d-82d6-3bb172d3f63fRevuforj 160 MG Oral Tablet [PSN] · revumenib 160 MG Oral Tablet [Revuforj] [SBD] · Revuforj 160 MG Oral Tablet [SY]35These highlights do not include all the information needed to use REVUFORJ safely and effectively. See full prescribing information for REVUFORJ. REVUFORJ (revumenib) tablets for oral use Initial U.S. Approval: 202420260204